Prøve GULL - Gratis

Specialised Skill Development for GCCs in India

Bio Spectrum

|

BioSpectrum India May 2025

India is a key hub for Life Sciences and Healthcare (LSHC) Global Capability Centers (GCCs).

- Sudeep Krishna, Co-Founder & President, Healthark Insights

Specialised Skill Development for GCCs in India

With over 280,000 professionals, 40 per cent are focused on clinical research and using AI for healthcare advancements. The AI talent pool in India is projected to grow to 633,000 by 2025, emphasising the need for specialised skills and continuous learning to maintain its reputation as a top destination for LSHC GCCs.

India has solidified its position as a pivotal hub for Global Capability Centers (GCCs), especially in the Life Sciences and Healthcare (LSHC) sectors. These centres are instrumental in driving advancements in research and development, digital transformation, regulatory compliance, pharmacovigilance, clinical trial analytics, and supply chain management for global pharmaceutical and healthcare enterprises. To sustain this momentum, developing a workforce with specialised skills is essential. Currently, LSHC GCCs in India employ over 280,000 professionals. Of this talent pool, 43 per cent are engaged in core healthcare and R&D, 16 per cent specialise in IT, and 41 per cent focus on business process management.

This article delves into the initiatives undertaken for skill development, the contributions of industry leaders, emerging competencies, and the role of GCC consortiums in fortifying the talent pipeline for LSHC GCCs in India.

Escalating Demand for Specialised Skills in LSHC GCCs

As India cements its status as a preferred destination for LSHC GCCs, there is an escalating demand for professionals proficient in Regulatory Affairs & Compliance for navigating guidelines from authorities such as the US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Central Drugs Standard Control Organisation (CDSCO) of India for drug approvals; Clinical Research & Data Management for executing clinical trials, analysing real-world evidence, and managing extensive healthcare datasets.

FLERE HISTORIER FRA Bio Spectrum

Bio Spectrum

Bio Spectrum

WHO certifies Suriname malaria-free

Suriname became the first country in the Amazon region to receive malaria-free certification from the World Health Organization (WHO).

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Torrent Pharma buys controlling stake in JB Pharma from KKR for Rs 25,689 Cr valuation

Ahmedabad-based Torrent Pharmaceuticals and global investment firm KKR have announced that Torrent has entered into definitive agreements to acquire controlling stake in Mumbai-based J. B. Chemicals and Pharmaceuticals (JB Pharma) from KKR at an Equity Valuation of Rs 25,689 crore (on fully diluted basis), followed by a merger of the two entities.

time to read

1 min

August 2025

Bio Spectrum

Suraksha Diagnostics injects Rs 22 Cr to establish Eastern India's largest genomics lab

Suraksha Diagnostics, one of the leading diagnostics chains in Eastern India, has launched one of the largest and a state-of-theart genomics lab in Eastern India.

time to read

1 min

August 2025

Bio Spectrum

Illumina buys SomaLogic for $425 M to accelerate proteomics business

Illumina, Inc. has entered into a definitive agreement with Standard BioTools under which Illumina will acquire SomaLogic, a leader in data-driven proteomics technology, and other specified assets for $350 million in cash payable at closing, subject to customary adjustments, plus up to $75 million in near-term performance-based milestones and performance-based royalties.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Kashmik Formulation to expand capacity, eyes Rs 100 Cr revenue in FY26

Kashmik Formulation, a pharmaceutical manufacturing company headquartered in Ahmedabad, has announced significant expansion plans aimed at increasing production capacity, strengthening its presence in international markets, and enhancing operational efficiencies through automation.

time to read

1 min

August 2025

Bio Spectrum

WHO highlights risks associated with use of semaglutide medicines

The World Health Organisation (WHO) is alerting healthcare professionals and regulatory authorities to the risk of non-arteritic anterior ischemic optic neuropathy (NAION) associated with the use of semaglutide medicinesOzempic, Rybelsus, and Wegovy.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Lamark Biotech secures Rs 6.5 Cr to accelerate development of thermostable insulin

Lamark Biotech, an innovation-led biopharma startup, has raised Rs 6.5 crore in a PreSeries A round led by IAN Group, including IAN Alpha Fund, powered by BioAngels, Dr Vinayender Tulla, Dr Nita Roy, and Venkataraman KNK, domain experts of IAN's angel investors led the round.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

AstraZeneca invests Rs 166 Cr to expand Global Hub in Bengaluru

AstraZeneca, a global, science-led biopharmaceutical company, has announced the expansion of its state-of-the-art Global Hub in Bengaluru, strengthening its presence in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Novo Nordisk launches injectable Semaglutide for weight management in India

Novo Nordisk, a leading global healthcare company headquartered in Denmark with over a 100-year legacy of chronic disease care, has announced the launch of Wegovy (injectable Semaglutide) in India.

time to read

1 min

August 2025

Bio Spectrum

Bio Spectrum

Can Policy Reforms & Investments Trigger India's MedTech MAKEOVER?

India's MedTech sector has long been import-dependent. The Centre is now working to change this by positioning the country as an export-oriented manufacturing hub. A series of policies and investments have been introduced to support this shift. Have these made an impact? What steps are necessary to strengthen India's position in the global medical technology (MedTech) landscape? Let's find out.

time to read

12 mins

August 2025

Listen

Translate

Share

-
+

Change font size